HOME >> MEDICINE >> NEWS
Sirolimus-eluting Coronary Stent outperforms paclitaxel eluting stent in seven study meta-analysis

WASHINGTON, D.C. (October 20, 2005) The most comprehensive and detailed analysis conducted to date of drug-eluting stent comparative trials shows a marked difference in the rate of target lesion revascularization (TLR) and restenosis in patients who received the CYPHER Stent vs. the Taxus Stent in seven studies totaling 4,214 patients. The CYPHER Stent vs. Taxus Stent meta-analysis was presented today to cardiologists and other attendees from throughout the world during the Cardiovascular Research Foundation's (CRF) 17th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

The purpose of this meta-analysis was to systematically review randomized comparative DES trials and obtain a more precise understanding of the true treatment effect of the CYPHER Stent and the Taxus Stent than any individual trial can provide.

Stephan Winndecker, M.D. and Peter Juni, M.D. of University Hospital Bern in Switzerland conducted a thorough review of clinical results from the head-to-head trials, analyzed extended patient follow-up data and initiated an extensive review of publications and information on these trials, many of which have been published in major medical journals.

The meta-analysis of the seven head-to-head drug-eluting stent trials TAXI, SIRTAX, ISAR DESIRE, ISAR DIABETES, REALITY, CORPAL and BASKET - demonstrated that the CYPHER Stent more effectively reduced the need for re-treatment, target lesion revascularization, by about 30% compared to Taxus Stent-treated patients.

"The benefit of the CYPHER Stent in reducing the need for re-treatment was observed in multiple patient and lesion types in this analysis," stated Dennis Donohoe, M.D., vice president of worldwide clinical research and regulatory affairs for Cordis Corporation. "This rigorously conducted meta analysis establishes the highest level of scientific evidence of the relative performance of these two drug-eluting stents. The CYPHER Stent's strong
'"/>

Contact: Todd Ringler
todd.ringler@edelman.com
781-599-7542
Edelman Public Relations
20-Oct-2005


Page: 1 2

Related medicine news :

1. CYPHER Sirolimus-eluting Coronary Stent benefits from clinical success, worldwide growth in 2005
2. Sirolimus-eluting Coronary Stent is cost effective vs. bypass surgery
3. Coronary surgery -- keeping the way clear
4. Coronary heart disease deaths in Ireland have halved in 15 years
5. Stenting of abdominal arteries offers welcome relief for intestinal angina
6. Stent-graft procedure improves outcomes of carotid aneurysm repair
7. Study finds patients with chronic total occlusions benefit from the CYPHER Stent
8. New study results suggest better outcomes with the CYPHER Stent than brachytherapy
9. Stents that release medication appear more effective than traditional stents
10. Drug-eluting stent controversy explored in the American Heart Hospital Journal
11. Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: